Giovanni Ponti

Giovanni Ponti

Auto-generated profile, based on publicly available information

Giovanni Ponti

Department of Surgical, Medical, Dental and Morphological Sciences with Interest Transplant, Oncological and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2005 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
PBPiero Benatti
Piero Benatti
ROBERTA GAFA'ROBERTA GAFA'
ROBERTA GAFA'
DBDaniela Barana
Daniela Barana
MMMassimiliano Marino
Massimiliano Marino
ASAlessandra Scarselli
Alessandra Scarselli
GLGiovanni Lanza
Giovanni Lanza
Purpose: Many studies have evaluated the role of high levels of microsatellite instability (MSI) as a prognostic marker and predictor of the response to chemotherapy in colorectal cancer (CRC); however, the results are not conclusive. The aim of this study was to analyze the prognostic significance of high levels of MSI (MSI-H) in CRC patients in relation to fluorouracil-based chemotherapy. Experimental Design: In three different institutions, 1,263 patients with CRC were tested for the presence of MSI, and CRC-specific survival was then analyzed in relation to MSI status, chemotherapy, and other clinical and pathologic variables. Results: Two hundred and fifty-six tumors were MSI-H (20.3%): these were more frequently at a less advanced stage, right-sided, poorly differentiated, with mucinous phenotype, and expansive growth pattern than microsatellite stable carcinomas. Univariate and multivariate analyses of 5-year–specific survival revealed stage, tumor location, grade of differentiation, MSI, gender, and age as significant prognostic factors. The prognostic advantage of MSI tumors was particularly evident in stages II and III in which chemotherapy did not significantly affect the survival of MSI-H patients. Finally, we analyzed survival in MSI-H patients in relation to the presence of mismatch repair gene mutations. MSI-H patients with hereditary non–polyposis colorectal cancer showed a better prognosis as compared with sporadic MSI-H; however, in multivariate analysis, this difference disappeared. Conclusions: The type of genomic instability could influence the prognosis of CRC, in particular in stages II and III. Fluorouracil-based chemotherapy does not seem to improve survival among MSI-H patients. The survival benefit for patients with hereditary non–polyposis colorectal cancer is mainly determined by younger age and less advanced stage as compared with sporadic MSI-H counterpart.

1 December 2005 in The Lancet Oncology
Verified
Journal Article
Closed access
GPGiovanni Ponti
Giovanni Ponti
MLMaurizio Ponz de Leon
Maurizio Ponz de Leon

20 January 2005 in Cancer
Verified
Journal Article
Open access
PDF file
GPGiovanni Ponti
Giovanni Ponti
Lorena LosiLorena Losi
Lorena Losi
CGCarmela Di Gregorio
Carmela Di Gregorio
Luca RoncucciLuca Roncucci
Luca Roncucci
MPMonica Pedroni
Monica Pedroni
MLMaurizio Ponz de Leon
Maurizio Ponz de Leon
BACKGROUND: The Muir–Torre syndrome (MTS) is an autosomal‐dominant genodermatosis characterized by the presence of sebaceous gland tumors, with or without keratoacanthomas, associated with visceral malignancies. A subset of patients with MTS is considered a variant of the hereditary nonpolyposis colorectal carcinoma, which is caused by mutations in mismatch‐repair genes. The objective of the current study was to evaluate whether a combined clinical, immunohistochemical, and biomolecular approach could be useful for the identification of Muir–Torre syndrome among patients with a diagnosis of sebaceous tumors and keratoacanthomas.METHODS: The authors collected sebaceous skin lesions and keratoacanthomas recorded in the files of the Pathology Department of the University of Modena during the period 1986–2000. Through interviews and examination of clinical charts, family trees were drawn for 120 patients who were affected by these skin lesions.RESULTS: Seven patients also were affected by gastrointestinal tumors, thus meeting the clinical criteria for the diagnosis of MTS. In the MTS families, a wide phenotypic variability was evident, both in the spectrum of visceral tumors and in the type of skin lesions. Microsatellite instability was found in five MTS patients: These patients showed concordance with immunohistochemical analysis; moreover, a constitutional mutation in the MSH2 gene was found in 1 patient. Lack of expression of MSH2/MSH6 or MLH1 proteins was evident in the skin lesions and in the associated internal malignancies of 3 patients and 2 patients with MTS, respectively.CONCLUSIONS: The clinical, biomolecular, and immunohistochemical characterization of sebaceous skin lesions and keratoacanthomas may be used as screening for the identification of families at risk of MTS, a disease that is difficult to recognize and diagnose. Cancer 2005. © 2005 American Cancer Society.

3 February 2013 in British Journal of Dermatology
Verified
Journal Article
Open access
PDF file
CLCaterina Longo
Caterina Longo
FFFrancesca Farnetani
Francesca Farnetani
SCS. Ciardo
S. Ciardo
ACA.M. Cesinaro
A.M. Cesinaro
EME. Moscarella
E. Moscarella
GPGiovanni Pellacani
Giovanni Pellacani
Background Nodular lesions pose diagnostic challenges because nodular melanoma may simulate all kinds of melanocytic and nonmelanocytic lesions. Reflectance confocal microscopy (RCM) is a novel technique that allows visualization of the skin at nearly histological resolution although limited laser depth penetration hampers visualization of the deep dermis. Objectives We sought to assess whether the diagnostic accuracy of RCM was comparable to histopathology for the diagnosis of nodular lesions, and to identify possible limitations of this technique. Methods We retrospectively evaluated 140 nodules by means of RCM while blinded from the histopathological diagnosis. At the end of the study the patient codes were broken and the evaluations were matched with histopathological diagnosis before performing statistical analysis. Results The study consisted of 140 nodular lesions (23 ‘pure’ nodular melanomas, nine melanoma metastases, 28 BCCs, six invasive SCCs, 32 naevi, 14 seborrhoeic keratoses, 17 dermatofibromas, five vascular lesions and six other lesions). RCM correctly diagnosed 121 of 140 lesions (86·4%); eight of 140 (5·7%) lesions revealed discordance between histopathology and confocal microscopy. Eight of the 140 (5·7%) cases were not evaluable by means of RCM due to the presence of ulceration or hyperkeratosis and three cases showed a nonspecific pattern. Interestingly, confocal microscopy reached a 96·5% sensitivity and 94·1% specificity (area under curve 0·970) (95% CI 0·924–1·015) (P < 0·001) for the diagnosis of melanoma. Conclusions The study is retrospective and lesions were not included on the basis of their diagnostic difficulty. Despite the limited laser depth penetration of RCM, this imaging tool represents an effective instrument in diagnosing nodular lesions; however, for fully ulcerated lesions or when a marked hyperkeratosis is present, biopsy should always be performed. Prospective studies on difficult‐to‐diagnose nodules should be performed to analyse further the pros and cons of RCM in skin cancer diagnosis.

1 October 2006 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
PDF file
GPGiovanni Ponti
Giovanni Ponti
Lorena LosiLorena Losi
Lorena Losi
MPMonica Pedroni
Monica Pedroni
ELEmanuela Lucci-Cordisco
Emanuela Lucci-Cordisco
CGCarmela Di Gregorio
Carmela Di Gregorio
SSStefania Seidenari
Stefania Seidenari

26 July 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SSStefania Seidenari
Stefania Seidenari
FAFederica Arginelli
Federica Arginelli
CDChristopher Dunsby
Christopher Dunsby
PFPaul M. W. French
Paul M. W. French
KKKarsten König
Karsten König
GPGiovanni Ponti
Giovanni Ponti
Multiphoton laser tomography (MPT) combined with fluorescence lifetime imaging (FLIM) is a non-invasive imaging technique, based on the study of fluorescence decay times of naturally occurring fluorescent molecules, enabling a non-invasive investigation of the skin with subcellular resolution. The aim of this retrospective observational ex vivo study, was to characterize melanoma both from a morphologic and a quantitative point of view, attaining an improvement in the diagnostic accuracy with respect to dermoscopy. In the training phase, thirty parameters, comprising both cytological descriptors and architectural aspects, were identified. The training set included 6 melanomas with a mean Breslow thickness±S.D. of 0.89±0.48 mm. In the test phase, these parameters were blindly evaluated on a test data set consisting of 25 melanomas, 50 nevi and 50 basal cell carcinomas. Melanomas in the test phase comprised 8 in situ lesions and had a mean thickness±S.D. of 0.77±1.2 mm. Moreover, quantitative FLIM data were calculated for special areas of interest. Melanoma was characterized by the presence of atypical short lifetime cells and architectural disorder, in contrast to nevi presenting typical cells and a regular histoarchitecture. Sensitivity and specificity values for melanoma diagnosis were 100% and 98%, respectively, whereas dermoscopy achieved the same sensitivity, but a lower specificity (82%). Mean fluorescence lifetime values of melanocytic cells did not vary between melanomas and nevi, but significantly differed from those referring to basal cell carcinoma enabling a differential diagnosis based on quantitative data. Data from prospective preoperative trials are needed to confirm if MPT/FLIM could increase diagnostic specificity and thus reduce unnecessary surgical excisions.